HS1 has a central role in the trafficking and homing of leukemic B cells

Blood

Volumn 116, Issue 18, 2010, Pages 3537-3546

  Scielzo, Cristina ^a,b   Bertilaccio, Maria T S ^a   Simonetti, Giorgia ^a,c   Dagklis, Antonis ^a   Ten Hacken, Elisa ^a   Fazi, Claudia ^a   Muzio, Marta ^a   Caiolfa, Valeria ^d,e   Kitamura, Daisuke ^f   Restuccia, Umberto ^a,b   Bachi, Angela ^a   Rocchi, Martina ^a   Ponzoni, Maurilio ^a   Ghia, Paolo ^a,g   Caligaris Cappio, Federico ^a,g  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF MILANO BICOCCA   (Italy)

^d Division of Surgical Oncology   (Italy)

^e ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

^f TOKYO UNIVERSITY OF SCIENCE   (Japan)

^g VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; F ACTIN; HEMATOPOIETIC CELL SPECIFIC LYN SUBSTRATE 1; UNCLASSIFIED DRUG;

ACTIN POLYMERIZATION; ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CELL ADHESION; CELL AGGREGATION; CELL MIGRATION; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; CYTOSKELETON; DISEASE COURSE; GENE REARRANGEMENT; HUMAN; HUMAN CELL; LYMPHOCYTE HOMING; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 78149309123     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-12-258814     Document Type: Article

References (38)

1. Kitamura D, Kaneko H, Miyagoe Y, Ariyasu T, Watanabe T. Isolation and characterization of a novel human gene expressed specifically in the cells of hematopoietic lineage. Nucleic Acids Res. 1989;17(22):9367-9379. (Pubitemid 20003196)
2. Fischer U, Michel A, Meese EU. Expression of the gene for hematopoietic cell specific protein is not restricted to cells of hematopoietic origin. Int J Mol Med. 2005;15(4):611-615.
3. Hao JJ, Zhu J, Zhou K, Smith N, Zhan X. The coiled-coil domain is required for HS1 to bind to F-actin and activate Arp2/3 complex. J Biol Chem. 2005;280(45):37988-37994.
4. Takemoto Y, Sato M, Furuta M, Hashimoto Y. Distinct binding patterns of HS1 to the Src SH2 and SH3 domains reflect possible mechanisms of recruitment and activation of downstream molecules. Int Immunol. 1996;8(11):1699-1705.
5. Gomez TS, McCarney SD, Carrizosa E, et al. HS1 functions as an essential actin-regulatory adaptor protein at the immune synapse. Immunity. 2006;24(6):741-752.
6. Carrizosa E, Gomez TS, Labno CM, et al. Hematopoietic lineage cell-specific protein 1 is recruited to the immunological synapse by IL-2-inducible T cell kinase and regulates phospholipase Cgamma1 Microcluster dynamics during T cell spreading. J Immunol. 2009;183(11):7352-7361.
7. Butler B, Kastendieck DH, Cooper JA. Differently phosphorylated forms of the cortactin homolog HS1 mediate distinct functions in natural killer cells. Nat Immunol. 2008;9(8):887-897.
8. Brunati AM, Deana R, Folda A, et al. Thrombin-induced tyrosine phosphorylation of HS1 in human platelets is sequentially catalyzed by Syk and Lyn tyrosine kinases and associated with the cellular migration of the protein. J Biol Chem. 2005;280(22):21029-21035.
9. Taniuchi I, Kitamura D, Maekawa Y, Fukuda T, Kishi H, Watanabe T. Antigen-receptor induced clonal expansion and deletion of lymphocytes are impaired in mice lacking HS1 protein, a substrate of the antigen-receptor- coupled tyrosine kinases. EMBO J. 1995;14(15):3664-3678.
10. Yamanashi Y, Fukuda T, Nishizumi H, et al. Role of tyrosine phosphorylation of HS1 in B cell antigen receptor-mediated apoptosis. J Exp Med. 1997;185(7):1387-1392.
11. Hao JJ, Carey GB, Zhan X. Syk-mediated tyrosine phosphorylation is required for the association of hematopoietic lineage cell-specific protein 1 with lipid rafts and B cell antigen receptor signalosome complex. J Biol Chem. 2004;279(32):33413-33420.
12. Scielzo C, Ghia P, Conti A, et al. HS1 protein is differentially expressed in chronic lymphocytic leukemia patient subsets with good or poor prognoses. J Clin Invest. 2005;115(6):1644-1650.
13. Muzio M, Scielzo C, Frenquelli M, et al. HS1 complexes with cytoskeleton adapters in normal and malignant chronic lymphocytic leukemia B cells. Leukemia. 2007;21(9):2067-2070.
14. Ghia P, Chiorazzi N, Stamatopoulos K. Microenvironmental influences in chronic lymphocytic leukaemia: the role of antigen stimulation. J Intern Med. 2008;264(6):549-562.
15. Caligaris-Cappio F, Ghia P. Novel insights in chronic lymphocytic leukemia: are we getting closer to understanding the pathogenesis of the disease? J Clin Oncol. 2008;26(27):4497-4503.
16. Richardson SJ, Matthews C, Catherwood MA, et al. ZAP-70 expression is associated with enhanced ability to respond to migratory and survival signals in B-cell chronic lymphocytic leukemia (B-CLL). Blood. 2006;107(9):3584-3592.
17. Lopez-Giral S, Quintana NE, Cabrerizo M, et al. Chemokine receptors that mediate B cell homing to secondary lymphoid tissues are highly expressed in B cell chronic lymphocytic leukemia and non-Hodgkin lymphomas with widespread nodular dissemination. J Leukoc Biol. 2004;76(2):462-471.
18. Stark RS, Liebes LF, Shelanski ML, Silber R. Anomalous function of vimentin in chronic lymphocytic leukemia lymphocytes. Blood. 1984;63(2):415-420.
19. Caligaris-Cappio F, Bergui L, Tesio L, Corbascio G, Tousco F, Marchisio PC. Cytoskeleton organization is aberrantly rearranged in the cells of B chronic lymphocytic leukemia and hairy cell leukemia. Blood. 1986;67(1):233-239.
20. Ramsay AG, Johnson AJ, Lee AM, et al. Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drug. J Clin Invest. 2008;118(7):2427-2437.
21. Bichi R, Shinton SA, Martin ES, et al. Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression. Proc Natl Acad Sci U SA. 2002;99(10):6955-6960.
22. Mulligan CS, Thomas ME, Mulligan SP. Lymphocytes, B lymphocytes, and clonal CLL cells: observations on the impact of the new diagnostic criteria in the 2008 Guidelines for Chronic Lymphocytic Leukemia (CLL). Blood. 2009;113(25):6496-6497; author reply 6497-6498.
23. Stacchini A, Aragno M, Vallario A, et al. MEC1 and MEC2: two new cell lines derived from Bchronic lymphocytic leukaemia in prolymphocytoid transformation. Leuk Res. 1999;23(2):127-136.
24. Seminario MC, Bunnell SC. Signal initiation in T-cell receptor microclusters. Immunol Rev. 2008;221:90-106.
25. Trautmann A. Microclusters initiate and sustain T cell signaling. Nat Immunol. 2005;6(12):1213-1214.
26. Ilani T, Vasiliver-Shamis G, Vardhana S, Bretscher A, Dustin ML. T cell antigen receptor signaling and immunological synapse stability require myosin IIA. Nat Immunol. 2009;10(5):531-539.
27. Mattila PK, Lappalainen P. Filopodia: molecular architecture and cellular functions. Nat Rev Mol Cell Biol. 2008;9(6):446-454.
28. Depoil D, Fleire S, Treanor BL, et al. CD19 is essential for B cell activation by promoting B cell receptor-antigen microcluster formation in response to membrane-bound ligand. Nat Immunol. 2008;9(1):63-72.
29. Schuuring E, van Damme H, Schuuring-Scholtes E, et al. Characterization of the EMS1 gene and its product, human Cortactin. Cell Adhes Commun. 1998;6(2-3):185-209.
30. Lai FP, Szczodrak M, Oelkers JM, et al. Cortactin promotes migration and platelet-derived growth factor-induced actin reorganization by signaling to Rho-GTPases. Mol Biol Cell. 2009;20(14):3209-3223.
31. Bertilaccio MT, Scielzo C, Simonetti G, et al. A novel Rag2-/-gammac-/--xenograft model of human CLL. Blood. 2010; 115(8):1605-1609.
32. Kaplan RN, Riba RD, Zacharoulis S, et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature. 2005;438(7069):820-827.
33. Lwin T, Crespo LA, Wu A, et al. Lymphoma cell adhesion-induced expression of B cell-activating factor of the TNF family in bone marrow stromal cells protects non-Hodgkin's B lymphoma cells from apoptosis. Leukemia. 2009;23(1):170-177.
34. Johnson AJ, Lucas DM, Muthusamy N, et al. Characterization of the TCL-1 transgenic mouse as a preclinical drug development tool for human chronic lymphocytic leukemia. Blood. 2006;108(4):1334-1338.
35. Huang Y, Burkhardt JK. T-cell-receptor-dependent actin regulatory mechanisms. J Cell Sci. 2007;120(Pt 5):723-730.
36. Yokoyama WM. Inhibitory receptors signal activation. Immunity. 2008;29(4):515-517.
37. Burkhardt JK, Carrizosa E, Shaffer MH. The actin cytoskeleton in T cell activation. Annu Rev Immunol. 2008;26:233-259.
38. Hartmann TN, Grabovsky V, Wang W, et al. Circulating B-cell chronic lymphocytic leukemia cells display impaired migration to lymph nodes and bone marrow. Cancer Res. 2009;69(7):3121-3130.